Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heavy Bupivacaine Versus Plain Bupivacaine in Peribulbar Block
NCT03312959Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Nov 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in Eye disease, sponsored by Cairo University. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
Eye disease
Beyond the preview
Go deeper on NCT03312959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03312959.